中国复发性急性心肌梗死的发生率、预测因素及预后影响
基于中国PEACE前瞻性AMI研究,纳入3387例出院存活的心梗患者,1年复发性AMI发生率为2.5%(95%CI 2.00-3.07),其中35.7%发生在30天内。复发性AMI与1年死亡强相关(校正HR 25.42,95%CI 15.27-42.34),早期复发者1年死亡率最高达53.3%。
要点
- 1年复发性心梗发生率为2.5%,超三分之一发生在出院后30天内。
- 复发性心梗显著增加1年死亡风险,校正HR达25.42。
- 高龄、入院心率快、肾功能不全及出院未用指南药物是复发预测因素。
核心结论
- 复发性AMI事件中约三分之一发生在早期,且与1年死亡率强烈相关,尤其是早期复发。
- 加强早期监测并改善出院指南药物处方可能减少中国复发性AMI。
研究设计与样本
- 基于中国PEACE前瞻性AMI研究,纳入53家医院3387例出院存活的AMI患者。
- 采用时间依赖Cox回归评估复发性AMI与1年死亡关联,Kaplan-Meier法和log-rank检验比较不同时期复发对死亡率影响,多变量模型识别相关因素。
主要发现
- 平均年龄60.7(11.9)岁,女性783例(23.1%)。
- 1年复发性AMI发生率为2.5%(95%CI 2.00-3.07),35.7%事件发生在最初30天内。
- 复发性AMI与1年死亡的校正HR为25.42(95%CI 15.27-42.34)。
- 早期复发性AMI的1年死亡率最高,为53.3%(log-rank p<0.001)。
关键数值与推荐
- 复发性AMI预测因素包括年龄75-84岁、院内行PCI、入院心率>90次/分、肾功能不全及出院未处方任何指南推荐药物。
临床怎么用
- 对AMI出院患者,尤其在出院后30天内,应加强监测以及时发现复发性AMI。
- 改善出院时指南推荐药物的处方可能有助于降低复发性AMI风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Incidence, predictors, and prognostic impact of recurrent acute myocardial infarction (AMI) after initial AMI remain poorly understood. Data on recurrent AMI in China is unknown. METHODS: Using the China Patient-centred Evaluative Assessment of Cardiac Events (PEACE)-Prospective AMI Study, we studied 3387 patients admitted to 53 hospitals for AMI and discharged alive. The association of recurrent AMI with 1-year mortality was evaluated using time-dependent Cox regression. Recurrent AMI events were classified as early (1-30 days), late (31-180 days), and very late (181-365 days). Their impacts on 1-year mortality were estimated by Kaplan-Meier methodology and compared by the log-rank test. Multivariable modelling was used to identify factors associated with recurrent AMI. RESULTS: The mean (SD) age was 60.7 (11.9) years and 783 (23.1%) were women. The observed 1-year recurrent AMI rate was 2.5% (95% CI 2.00 to 3.07) with 35.7% events occurring within the first 30 days. Recurrent AMI was associated with 1-year mortality with an adjusted HR of 25.42 (95% CI 15.27 to 42.34). Early recurrent AMI was associated with the highest 1-year mortality rate of 53.3% (log-rank p<0.001). Predictors of recurrent AMI included age 75-84, in-hospital percutaneous coronary intervention, heart rate >90 min/beats at initial admission, renal dysfunction, and not being prescribed any of guideline-based medications at discharge. CONCLUSIONS: One-third of recurrent AMI events occurred early. Recurrent AMI is strongly associated with 1-year mortality, particularly if early. Heightened surveillance during this early period and improving prescription of recommended discharge medications may reduce recurrent AMI in China.
引用
- Song J, Murugiah K, Hu S, et al. Incidence, predictors, and prognostic impact of recurrent acute myocardial infarction in China. Heart. 2020. PMID: 32938773. doi:10.1136/heartjnl-2020-317165
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。